The Collaborators - Developing a New Class of Medicines

The Collaborators are working to ensure that people around the world who may benefit from innovative RNAi therapeutics, have access to them. These collaborators include Alnylam employees as well as payers, regulators and government employees. Through Alnylam's Patient Access Philosophy, and innovative pricing agreements such as Value Based Agreements, Alnylam is working to be as innovative in the way that we commercialize our medicines as we are in developing them.

This is the sixth video in a seven part series, which is being released in installments over the coming months. Each represents a stage in the journey to develop RNAi therapeutics and in them, you’ll meet the dreamers, pioneers, believers, makers, collaborators and futurists who’s confidence in the potential of therapeutic value of RNAi has been critical to Alnylam’s story and the heroes on the front lines of fighting rare diseases every day. Please subscribe to this channel to be notified when the new videos are released.

Learn more about us at alnylam.com.

Alnylam,ALNY,$ALNY,RNAi,RNAi therapeutics,RNA interference,Alnylam Pharmaceuticals,Value Based Agreement,